Skip to content
Catalyst

PapersPMID:27763802

A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms.

Climacteric2016The record ↗

  1. Finding, very limited evidencelowersKupperman Menopausal Index total score

What moved

1 findingHow to read these marks →
  • “Total KI scores were significantly lower in the BMO-30 group than in the placebo group when evaluated with respect to group and time (p = 0.042).”
    Study
    RCT
    Dose studied
    treatment for 6 weeks, followed for 12 weeks; dose not stated in the abstract
    Population
    Women aged 40 to 70 years complaining of menopausal symptoms on the Kupperman Index; 41 eligible, 36 completed (18 per group); group-by-time analysis over the 12-week follow-up

Study record

Design
randomised controlled trial
Species
human
Population
Women between the ages of 40 and 70 years complaining of menopausal symptoms measured by the Kupperman Index
Participants
36
Comparator
placebo
Duration
42 days
Endpoints measured
4